Printer Friendly

Browse Biotechnology industries topic

Subtopics (170)

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Regencell Bioscience Posts Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19 in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period. May 19, 2022 913
PDS Biotechnology names senior vice president Business Development. May 19, 2022 214
Thermo Fisher Scientific Partners with LabShares to Support Emerging Boston Biotechs. May 19, 2022 169
Thermo Fisher Scientific Partners with LabShares to Support Emerging Boston Biotechs. May 19, 2022 182
Adverum Biotechnologies presents research piepline data at ASGCT. May 19, 2022 314
PDS Biotechnology names senior vice president Business Development. May 19, 2022 213
LATEST COMPANY NEWS. May 18, 2022 25283
Precision BioSciences publishes data from in vivo gene editing program. May 18, 2022 292
Pfizer and BioNTech granted US EUA for booster dose of their COVID-19 vaccine in children 5 to 11. May 18, 2022 260
Pfizer and BioNTech granted US EUA for booster dose of their COVID-19 vaccine in children 5 to 11. May 18, 2022 259
LATEST COMPANY NEWS. May 17, 2022 13842
LATEST COMPANY NEWS. May 17, 2022 23587
Entasis Therapeutics presents data highlights from Phase 3 ATTACK trial. May 17, 2022 268
First Patient Dosed in Phase 1 Trial to Test Cancer-Killing Oncolytic Virus Against Solid Tumors. May 17, 2022 692
Emergent BioSolutions to Acquire Rights to Tembexa from Chimerix for Up to USD 325m. May 17, 2022 158
Emergent BioSolutions to Acquire Rights to Tembexa from Chimerix for Up to USD 325m. May 17, 2022 187
Gulf Biotech to manufacture injectable drugs. May 12, 2022 290
VeriSIM Life Acquires Spanish Drug Discovery Firm Molomics Biotech. May 12, 2022 231
VeriSIM Life Acquires Spanish Drug Discovery Firm Molomics Biotech. May 12, 2022 255
Chess Named to BigHat Biosciences Board of Directors. May 12, 2022 261
Bio-Techne and Nonagen Bioscience enter supply agreement for bladder cancer test. May 12, 2022 165
Precision BioSciences announces grant of inducement awards under Nasdaq rule. May 12, 2022 168
Aadi Bioscience reports Q1 EPS (66c), consensus (71c). Financial report May 12, 2022 190
Skye Bioscience signs arrangement agreement with Emerald Health Therapeutics. May 12, 2022 324
MorphoSys to present new data on Pelabresib and Monjuvi at EHA and ASCO. May 12, 2022 191
Imago BioSciences reports Q1 EPS (49c), consensus (43c). Financial report May 12, 2022 248
LATEST COMPANY NEWS. May 11, 2022 25684
Dare Bioscience announces NIH grant award of $249,000. May 11, 2022 153
COVID vaccine makers shift focus to boosters. May 11, 2022 689
Novamind to host Bionomics PREVAIL Trial for treatment of SAD. Clinical report May 10, 2022 218
SQZ Biotechnologies to Make First Data Presentation on Non-Clinical Studies of Point-of-Care Manufacturing System and Collaboration with Stemcell Technologies on Research-Use-Only System to Fuel Preclinical Research. Clinical report May 10, 2022 507
Clue Genetics Acquires Rare Fungus Collection from Mycosynthetix. May 10, 2022 159
LATEST COMPANY NEWS. May 10, 2022 16022
LATEST COMPANY NEWS. May 10, 2022 22508
Precision BioSciences reports Q1 EPS (46c), consensus (54c). Financial report May 9, 2022 211
Amicus reports Q1 EPS (30c), consensus (25c). Financial report May 9, 2022 173
Twist Bioscience Astellas collaborate for antibodies to reduce TME. May 9, 2022 211
Harbour BioMed adds Scientific Advisory Board member. May 6, 2022 182
Harbour BioMed adds Scientific Advisory Board member. May 6, 2022 183
Myriad Genetics reports Q1 adjusted EPS (3c), consensus (7c). Financial report May 5, 2022 178
Accelerated Biosciences, Pluristyx Launch Human Trophoblast Stem Cell Derived iPSCs. May 5, 2022 295
Harvard Bioscience reports Q1 adjusted EPS 4c, consensus 5c. Financial report May 4, 2022 275
Unchained Labs Acquires Boston-Based Biotech NanoView Biosciences. May 4, 2022 243
Unchained Labs Acquires Boston-Based Biotech NanoView Biosciences. May 4, 2022 265
LATEST COMPANY NEWS. May 4, 2022 27374
Bishop Named to DTx Pharma Board of Directors. May 3, 2022 320
Imago BioSciences completes enrollment in Phase 2 study of bomedemstat. Report May 3, 2022 165
Horizon Therapeutics Receives European Commission Approval of Uplizna for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder. May 3, 2022 800
LATEST COMPANY NEWS. May 3, 2022 17006
LATEST COMPANY NEWS. May 2, 2022 36037
FDA Advisory Committee Meeting to Review Acadia Pharmaceuticals' Resubmission of Supplemental New Drug Application for Nuplazid for the Treatment of Alzheimer's Disease Psychosis Scheduled for June 17. May 2, 2022 383
NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target. Huang, Hongbo; Hua, Qingwang Apr 30, 2022 5031
Moderna seeks US authorization for Covid vaccine in children under 6. Apr 29, 2022 634
Moderna seeks US authorisation for its COVID-19 vaccine for young children. Apr 29, 2022 154
Moderna seeks US authorisation for its COVID-19 vaccine for young children. Apr 29, 2022 158
I-Mab names new chief operating officer and new chief medical officer. Apr 29, 2022 253
Moderna seeks US authorisation for its COVID-19 vaccine for young children. Apr 29, 2022 157
I-Mab names new chief operating officer and new chief medical officer. Apr 29, 2022 252
Enamel Matrix Derivative Enhances the Odontoblastic Differentiation of Dental Pulp Stem Cells via Activating MAPK Signaling Pathways. Zhang, Beidi; Xiao, Min; Cheng, Xiaogang; Bai, Yu; Chen, Hanze; Yu, Qing; Qiu, Lihong Apr 28, 2022 8330
Pluristyx to Manufacture Clinical Grade hTSC Bank Under New Pact with Accelerated Biosciences. Apr 28, 2022 285
Vir Biotechnology announces new data from MARCH hepatitis B trial. Apr 27, 2022 412
Valneva, Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate. Report Apr 27, 2022 605
Caladrius Biosciences, Cend Therapeutics to Merge. Apr 27, 2022 456
Caladrius Biosciences, Cend Therapeutics to Merge. Apr 27, 2022 435
Pfizer/ BioNTech apply for authorisation to US FDA for COVID-19 booster shot in younger children. Apr 27, 2022 190
Pfizer/ BioNTech apply for authorisation to US FDA for COVID-19 booster shot in younger children. Apr 27, 2022 187
Pfizer/ BioNTech apply for authorisation to US FDA for COVID-19 booster shot in younger children. Apr 27, 2022 191
LATEST COMPANY NEWS. Apr 27, 2022 27888
LATEST COMPANY NEWS. Apr 26, 2022 16992
EU regulator requires more data from Valneva on its COVID-19 vaccine before authorising conditional marketing request. Apr 26, 2022 193
EU regulator requires more data from Valneva on its COVID-19 vaccine before authorising conditional marketing request. Apr 26, 2022 194
EU regulator requires more data from Valneva on its COVID-19 vaccine before authorising conditional marketing request. Apr 26, 2022 190
Valneva and Pfizer partnership announces positive Phase 2 paediatric data for Lyme Disease vaccine candidate,VLA15. Apr 26, 2022 302
Valneva and Pfizer partnership announces positive Phase 2 paediatric data for Lyme Disease vaccine candidate,VLA15. Apr 26, 2022 306
Valneva and Pfizer partnership announces positive Phase 2 paediatric data for Lyme Disease vaccine candidate,VLA15. Apr 26, 2022 305
Myriad Genetics report results on nationwide survey. Apr 26, 2022 218
Harvard Bioscience introduces new feature to its Buxco Inhalation System. Apr 26, 2022 177
Nkarta's AML/NHL data 'a positive' for CAR-NK space, says Stifel. Apr 26, 2022 164
ILiAD Biotechnologies Receives NIH Grant to Develop Novel Tuberculosis Vaccine Using Proprietary B-Tech Vector Platform. Apr 26, 2022 809
Vitrac Therapeutics Initiates a Phase 1/2 Clinical Trial with the Aurora Kinase A inhibitor VIC-1911 in GVHD Prophylaxis. Apr 26, 2022 406
£2.5m to help Newcastle biotech firm launch world-first skin cancer test in the UK and USA; Newcastle Uni spin-out company AMLo Biosciences has received almost £2.5m to help it launch a new skin cancer test which could help reduce the mammoth pressure on the NHS. By, Sam Volpe Apr 26, 2022 696
Nektar announces new strategic reorganization plan. Apr 25, 2022 469
Seagen Plans to Expand Pacific Northwest Biomanufacturing Capacity to Support Growing Portfolio of Transformative Cancer Medicines. Apr 22, 2022 314
CureVac and GSK's experimental COVID-19 vaccine effective against two variants in mice. Apr 22, 2022 179
Portal Innovations enters into scientific equipment and resources partnership with Thermo Fisher Scientific. Apr 22, 2022 181
CureVac and GSK's experimental COVID-19 vaccine effective against two variants in mice. Apr 22, 2022 175
Portal Innovations enters into scientific equipment and resources partnership with Thermo Fisher Scientific. Apr 22, 2022 177
CureVac and GSK's experimental COVID-19 vaccine effective against two variants in mice. Apr 22, 2022 178
CureVac, GSK announces preclinical data on second-generation COVID vaccine. Apr 21, 2022 296
Pacific Bioscience releases new update to its HiFi sequencing technology. Apr 21, 2022 185
Legend Biotech Achieves Milestone Under Collaboration Agreement with Janssen Biotech, Inc. for BCMA CAR-T. Apr 21, 2022 370
Role of the Long Intergenic Non-Protein-Coding RNA 1278/miR-185-5p/Cystatin SN Axis in Laryngeal Cancer Cells. Shen, Bin; Ding, Haibin; Ye, Yanyan; Luo, Baozhen Apr 21, 2022 4033
Acadia Pharmaceuticals Posts Top-Line Results from Phase 2 Study Evaluating ACP-044 for the Treatment of Acute Postoperative Pain. Apr 20, 2022 656
LATEST COMPANY NEWS. Apr 20, 2022 25834
Moderna says dual variant COVID-19 booster against Beta variant more effective against Omicron than current shot. Apr 20, 2022 201
Moderna says dual variant COVID-19 booster against Beta variant more effective against Omicron than current shot. Apr 20, 2022 198
Moderna says dual variant COVID-19 booster against Beta variant more effective against Omicron than current shot. Apr 20, 2022 202
LATEST COMPANY NEWS. Apr 19, 2022 26988
LATEST COMPANY NEWS. Apr 19, 2022 15546
Lexaria Bioscience commences human clinical hypertension study. Clinical report Apr 19, 2022 578
Lexaria Bioscience begins multi-week human clinical hypertension study. Clinical report Apr 19, 2022 199
Acadia Pharmaceuticals says primary endpoint in ACP-044 phase 2 trial not met. Apr 18, 2022 168
Albumedix Ltd. expands collaboration with Valneva SE. Apr 18, 2022 278
Albumedix Ltd. expands collaboration with Valneva SE. Apr 18, 2022 279
Gulf Biotech to manufacture injectable drugs in Bahrain. Apr 17, 2022 315
NHRA licenses Gulf Biotech to manufacture injectable drugs. Apr 16, 2022 297
SQZ Biotechnologies Presents New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In Vivo. Apr 14, 2022 698
Nektar, Bristol-Myers to end development program for bempegaldesleukin/Opdivo. Apr 14, 2022 334
UK approves Valneva's COVID-19 vaccine. Apr 14, 2022 177
UK approves Valneva's COVID-19 vaccine. Apr 14, 2022 178
UK approves Valneva's COVID-19 vaccine. Apr 14, 2022 174
Pfizer/BioNTech's trial shows booster dose increases protection against Omicron COVID-19 variant in children aged five to 11 years. Apr 14, 2022 210
BCD Bioscience closes the oversubscribed USD12m Series A funding. Apr 14, 2022 159
Pfizer/BioNTech's trial shows booster dose increases protection against Omicron COVID-19 variant in children aged five to 11 years. Apr 14, 2022 211
Pfizer/BioNTech's trial shows booster dose increases protection against Omicron COVID-19 variant in children aged five to 11 years. Apr 14, 2022 207
Diamyd Medical AB announces clinical trial of Diamyd booster in diabetes patients. Apr 14, 2022 181
Diamyd Medical AB announces clinical trial of Diamyd booster in diabetes patients. Apr 14, 2022 176
Diamyd Medical AB announces clinical trial of Diamyd booster in diabetes patients. Apr 14, 2022 179
Diamyd Medical AB announces clinical trial of Diamyd booster in diabetes patients. Apr 14, 2022 180
Pfizer, BioNTech announce results from trial of vaccine booster dose in children. Apr 14, 2022 455
Lexaria Bioscience completes all data analyses from HYPER-H21-3 study. Clinical report Apr 14, 2022 264
Lexaria Bioscience announces data from HYPER-H21-3 study. Clinical report Apr 14, 2022 261
Neuron23 Inc names new CMO. Apr 13, 2022 176
Novavax's first protein-based COVID-19 vaccine authorized for use in Switzerland. Apr 13, 2022 218
Neuron23 Inc names new CMO. Apr 13, 2022 177
Novavax's first protein-based COVID-19 vaccine authorized for use in Switzerland. Apr 13, 2022 219
Novavax's first protein-based COVID-19 vaccine authorized for use in Switzerland. Apr 13, 2022 215
LATEST COMPANY NEWS. Apr 13, 2022 28114
Dare Bioscience imitates Phase 1/2 clinical study of DARE-HRT1. Clinical report Apr 12, 2022 190
Lexaria Bioscience updates nicotine study NIC-H22-1, sees dosing this summer. Clinical report Apr 12, 2022 192
Lexaria Bioscience announces details of human nicotine study NIC-H22-1. Report Apr 12, 2022 408
Ansa Biotechnologies Closes Oversubscribed USD 68m Series A Financing to Power the Next Era of DNA-Enabled Industries. Apr 12, 2022 558
LATEST COMPANY NEWS. Apr 12, 2022 16383
Axol Bioscience Raises GBP 3.2m in Extension of Previous Funding Round. Apr 11, 2022 176
Trinity Biotech enters $45M strategic investment, partnership with MiCo. Apr 11, 2022 680
Nancy Pelosi's infection brings Covid closer than ever to Biden. Apr 8, 2022 682
Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell Therapies. Apr 8, 2022 320
PDS Biotechnology reports inducement grants under Nasdaq listing rule. Apr 8, 2022 169
Aadi Bioscience announces data presentation at AACR on TCS1, TSC2 alterations. Apr 8, 2022 211
Axol Bioscience Ltd raises GBP3.2m in additional funding. Apr 7, 2022 179
Axol Bioscience Ltd raises GBP3.2m in additional funding. Apr 7, 2022 178
Twist Bioscience, Ginkgo Bioworks Ink Supply Pact. Apr 7, 2022 272
Fujifilm Buys Atara Biotherapeutics Cell Therapy Manufacturing Facility. Apr 6, 2022 302
Fujifilm Buys Atara Biotherapeutics Cell Therapy Manufacturing Facility. Apr 6, 2022 325
COVAX and African Union decline options to buy more doses of Moderna's COVID-19 vaccines. Apr 6, 2022 230
COVAX and African Union decline options to buy more doses of Moderna's COVID-19 vaccines. Apr 6, 2022 229
COVAX and African Union decline options to buy more doses of Moderna's COVID-19 vaccines. Apr 6, 2022 226
LATEST COMPANY NEWS. Apr 6, 2022 26804
LATEST COMPANY NEWS. Apr 5, 2022 14748
LATEST COMPANY NEWS. Apr 5, 2022 16729
Roche, world's biggest biotech company, officially opens new site in Cape Town. Apr 5, 2022 390
Avidity Biosciences expands Michael MacLean's role to Chief Business Officer. Apr 5, 2022 152
CARB-X Awards Clarametyx Biosciences USD 3.89m in Additional Option Funding to Accelerate Anti-Biofilm Technology for Life-Threatening Bacterial Infections. Apr 4, 2022 448
ATCC Expands Bioinformatics Data Platform with Qiagen. Apr 4, 2022 437
Fujifilm Closes Acquisition of Shenandoah Biotechnology. Apr 1, 2022 177
BigHat Biosciences Closes Acquisition of Protein Synthesis Technology Developer Frugi Biotechnology. Apr 1, 2022 270
Fujifilm Closes Acquisition of Shenandoah Biotechnology. Apr 1, 2022 198
BigHat Biosciences Closes Acquisition of Protein Synthesis Technology Developer Frugi Biotechnology. Apr 1, 2022 296
Organon to acquire global rights to XACIATO vaginal gel from DarA(c) Bioscience. Apr 1, 2022 228
Organon to acquire global rights to XACIATO vaginal gel from DarA(c) Bioscience. Apr 1, 2022 229
Novavax files conditional marketing authorization of COVID-19 vaccine in the EU for adolescents ages 12-17. Mar 31, 2022 236
Novavax files conditional marketing authorization of COVID-19 vaccine in the EU for adolescents ages 12-17. Mar 31, 2022 237
Novavax files conditional marketing authorization of COVID-19 vaccine in the EU for adolescents ages 12-17. Mar 31, 2022 233
Dare Bioscience reports 2021 EPS (63c), consensus (65c). Financial report Mar 31, 2022 186
hAMSC Sheet Promotes Repair of Rabbit Osteochondral Defects. Zou, Gang; Zhang, Jun; Yang, Qifan; Wang, Xiaoyan; Sun, Pengpeng Mar 31, 2022 7935
LATEST COMPANY NEWS. Mar 30, 2022 26971
The FDA announces amendment of COVID-19 booster vaccines for older and immunocompromised individuals. Mar 30, 2022 235
The FDA announces amendment of COVID-19 booster vaccines for older and immunocompromised individuals. Mar 30, 2022 231
The FDA announces amendment of COVID-19 booster vaccines for older and immunocompromised individuals. Mar 30, 2022 234
CureVac, GSK start clinical development of CV2CoV COVID-19 vaccine candidate. Mar 30, 2022 285
LetsGetChecked to Acquire Veritas Genetics, Veritas Intercontinental. Mar 30, 2022 320
LetsGetChecked to Acquire Veritas Genetics, Veritas Intercontinental. Mar 30, 2022 298
Concentric Analgesics Touts Positive Results from Pilot Phase 2 Clinical Trial of Vocacapsaicin. Mar 30, 2022 227
Assure us of policy continuity. Mar 30, 2022 768
United Airlines, Oxy Low Carbon Ventures Work with Biotech Firm to Create New Fuel Sources. Mar 30, 2022 337
United Airlines, Oxy Low Carbon Ventures Work with Biotech Firm to Create New Fuel Sources. Mar 30, 2022 320
US FDA mulling over benefits of additional round of COVID-19 boosters for more people in autumn. Mar 30, 2022 166
US FDA authorises second booster of Pfizer/BioNTech COVID-19 shot for people over 50 years. Mar 30, 2022 251
US FDA mulling over benefits of additional round of COVID-19 boosters for more people in autumn. Mar 30, 2022 167
US FDA authorises second booster of Pfizer/BioNTech COVID-19 shot for people over 50 years. Mar 30, 2022 252
US FDA authorises second booster of Pfizer/BioNTech COVID-19 shot for people over 50 years. Mar 30, 2022 248
National Vaccine Institute Bill to go before Parliament soon - President Akufo- Addo. Mar 29, 2022 206
Fujifilm closes acquisition of Shenandoah Biotechnology. Mar 29, 2022 161
Fujifilm closes acquisition of Shenandoah Biotechnology. Mar 29, 2022 162
Sangamo Therapeutics Doses First Patient in Phase 1/2 Clinical Study of Investigational CAR-Treg Cell Therapy TX200 in Kidney Transplantation. Clinical report Mar 29, 2022 1015
LATEST COMPANY NEWS. Mar 29, 2022 16333
LATEST COMPANY NEWS. Mar 29, 2022 18490
Novavax announces two booster studies to evaluate its COVID-19 Vaccine, NVX-CoV2373. Mar 28, 2022 318
Novavax announces two booster studies to evaluate its COVID-19 Vaccine, NVX-CoV2373. Mar 28, 2022 317
Planned vaccines production plant a big win for Kenya. Mar 27, 2022 763
Taiwan to buy 2 million doses of Novavax COVID vaccine. Mar 24, 2022 243
Fujifilm to Acquire Shenandoah Biotechnology. Mar 24, 2022 207
Fujifilm to Acquire Shenandoah Biotechnology. Mar 24, 2022 227
'Safety data ... is excellent'. Marni Pyke mpyke@dailyherald.com Mar 24, 2022 625
'Safety data ... is excellent' Vaccine: Dose is about a quarter of adult's. Marni Pyke mpyke@dailyherald.com Mar 24, 2022 1000
'Safety data ... is excellent' Vaccine: Dose is about a quarter of an adult's. Marni Pyke mpyke@dailyherald.com Mar 24, 2022 1000
'Safety data ... is excellent' Vaccine: Dose is about a quarter of adult's. Marni Pyke mpyke@dailyherald.com Mar 24, 2022 625
'It's been difficult waiting': What to know about Moderna's proposed vaccine for kids under 6. Marni Pyke mpyke@dailyherald.com Mar 24, 2022 625
Imago BioSciences reports Q4 EPS (44c), consensus (39c). Financial report Mar 24, 2022 239
LATEST COMPANY NEWS. Mar 23, 2022 27926
LATEST COMPANY NEWS. Mar 22, 2022 14791
LATEST COMPANY NEWS. Mar 22, 2022 15627
Aulos Bioscience Posts Preclinical Data Demonstrating Ability of Novel IL-2 Therapeutic AU-007 to Eliminate Solid Tumors. Mar 22, 2022 587
Viva Biotech adds to production of oral COVID-19 drug molnupiravir in the joint fight against COVID-19. Mar 21, 2022 249
Viva Biotech adds to production of oral COVID-19 drug molnupiravir in the joint fight against COVID-19. Mar 21, 2022 248
SQZ Biotechnologies Announces USD 2m Grant from the National Institutes of Health to Develop a Novel, Scalable Cell Replacement Therapy for Parkinson's Disease. Mar 21, 2022 331
Atom Bioscience Touts Positive Phase 2a Results for Investigational New Drug to Treat Chronic Gout. Mar 21, 2022 304
Animal Vaccine Maker Plans Move to Arkansas. Mar 21, 2022 319
Moderna seeks FDA authorisation for second COVID booster for all adults. Mar 19, 2022 239
Alnylam Pharmaceuticals files patent infringement lawsuits against Pfizer and Moderna over COVID-19 vaccines. Mar 18, 2022 198
Alnylam Pharmaceuticals files patent infringement lawsuits against Pfizer and Moderna over COVID-19 vaccines. Mar 18, 2022 199
Alnylam Pharmaceuticals files patent infringement lawsuits against Pfizer and Moderna over COVID-19 vaccines. Mar 18, 2022 195
Coronavirus: Canadian Pfizer partner sues to head off patent lawsuit over Covid-19 vaccine. Reuters News Service Mar 18, 2022 235
Moderna requests FDA okay for 4th Covid shot for adults. Mar 18, 2022 297
Pressure BioSciences provides update on key 2022 goals. Mar 17, 2022 224
Genentech Touts New Evrysdi Data Demonstrating Long-Term Efficacy and Safety in a Broad Population of People with Spinal Muscular Atrophy. Mar 16, 2022 618
SQZ Biotechnologies reports FY21 EPS ($2.49), consensus ($2.75). Financial report Mar 16, 2022 166
Pfizer-BioNTech seek US regulatory approval for second COVID-19 booster shot for 65 years and above. Mar 16, 2022 222
Pfizer-BioNTech seek US regulatory approval for second COVID-19 booster shot for 65 years and above. Mar 16, 2022 223
Pfizer-BioNTech seek US regulatory approval for second COVID-19 booster shot for 65 years and above. Mar 16, 2022 219
Yield10 Bioscience CEO to present on development of Camelina at ABLC. Mar 16, 2022 171
LATEST COMPANY NEWS. Mar 16, 2022 26227
LATEST COMPANY NEWS. Mar 15, 2022 17186
PDS Biotechnology says NCi achieves enrollment objective in Phase 2 trial. Mar 15, 2022 209
Sophia Genetics and Realm IDx to Collaborate in Accelerating Cancer Research. Mar 15, 2022 524
CanSinoBIO's Convidecia approved as Heterologous Booster in China. Mar 15, 2022 426
Evidence for ABL Amplification in Multiple Myeloma and Therapeutic Implications. Huang, He; Zhou, Shuping; Lin, Hongdou; Guo, Wenjian; Lin, Ying; Yao, Ronxin; He, Licai Mar 15, 2022 5063
EU's roll out of Novavax's COVID-19 vaccine off to a slow start. Mar 14, 2022 352
EU's roll out of Novavax's COVID-19 vaccine off to a slow start. Mar 14, 2022 355
EU's roll out of Novavax's COVID-19 vaccine off to a slow start. Mar 14, 2022 356
Synthetic Biologics Closes Acquisition of Spanish Biotech VCN Biosciences. Mar 14, 2022 322
Synthetic Biologics Closes Acquisition of Spanish Biotech VCN Biosciences. Mar 14, 2022 346
Bristol-Myers, Nektar provide update on Phase 3 PIVOT IO-001 trial. Mar 14, 2022 261
Myriad Genetics launches Precise Oncology Solutions offering. Mar 14, 2022 346
Liminal BioSciences provides update on lead drug candidate fezagepras. Mar 14, 2022 365
Bristol Myers Squibb, Nektar Post Update on Phase 3 PIVOT IO-001 Trial Evaluating Bempegaldesleukin in Combination with Opdivo (nivolumab) in Previously Untreated Unresectable or Metastatic Melanoma. Mar 14, 2022 557
Applied DNA Executes LOI with Spindle Biotech for Research Collaboration on Simplified High Yield mRNA Production System. Mar 14, 2022 551
US Biotech InSitu Biologics Joins the in5 Incubator in UAE. Mar 11, 2022 207
Acadia Pharmaceuticals Receives Target Action Date for Resubmitted Supplemental New Drug Application for Nuplazid for the Treatment of Alzheimer's Disease Psychosis. Mar 10, 2022 325
Colossal Secures USD 60m series A Funding to Advance Genetic Engineering and De-extinction Technologies. Mar 9, 2022 519
LATEST COMPANY NEWS. Mar 9, 2022 25675
LATEST COMPANY NEWS. Mar 8, 2022 16407
Moderna to set up mRNA vaccine manufacturing facility in Kenya. Reuters News Service Mar 8, 2022 297
US FDA Grants Priority Review of the Supplemental Biologics License Application for the Concomitant Use of Krystexxa Plus Methotrexate for People Living with Uncontrolled Gout. Mar 8, 2022 237
Puma Biotechnology announces grant of inducement restricted stock unit as part of Nasdaq Listing Rule 5635(c)(4). Mar 7, 2022 181
Puma Biotechnology announces grant of inducement restricted stock unit as part of Nasdaq Listing Rule 5635(c)(4). Mar 7, 2022 182
AbbVie Acquires Belgian Biotechnology Firm Syndesi Therapeutics for USD 130m Upfront. Mar 4, 2022 386
AbbVie Acquires Belgian Biotechnology Firm Syndesi Therapeutics for USD 130m Upfront. Mar 4, 2022 361
Ashford-Hicks Named Chief Executive Officer at Cayuga Biotech. Mar 3, 2022 296
LATEST COMPANY NEWS. Mar 2, 2022 29319
LATEST COMPANY NEWS. Mar 1, 2022 27295
LATEST COMPANY NEWS. Mar 1, 2022 17169
Newly developed inhaled vaccine delivers broad protection against SARSCoV-2, variants of concern. Mar 1, 2022 582
Follow the Virus: GENOMIC SURVEILLANCE IS HELPING US SPOT NEW VARIANTS AND FIGURE OUT HOW TO RESPOND. Nordling, Linda Mar 1, 2022 2756
Arbutus Biopharma files patent infringement lawsuit against Moderna related to its COVID-19 vaccines. Feb 28, 2022 206
Arbutus Biopharma files patent infringement lawsuit against Moderna related to its COVID-19 vaccines. Feb 28, 2022 205
Profiling of Apoptosis-Related Genes in Erythrocytes of Chickens Infected with Avian Influenza Virus (h9N2 Subtype). Muhammad Farhan Qadir, Xin-Yu han, Meng-li Qiao, Qian-qian Cheng, Raza Ali Mangi, Ali Raza Jahejo, A Feb 28, 2022 4264
Compugen names new director. Feb 25, 2022 179
Compugen names new director. Feb 25, 2022 178
Aulos Bioscience Receives HREC Approval to Initiate First-in-Human Clinical Trial Evaluating Anti-Tumor Activity of Novel IL-2 Therapeutic AU-007. Feb 24, 2022 413
Moderna and Thermo Fisher Scientific Ink Long-Term Strategic Collaboration. Feb 24, 2022 323
Horizon Therapeutics Initiates Phase 3 Clinical Trial (OPTIC-J) in Japan Evaluating Teprotumumab for the Treatment of Active Thyroid Eye Disease. Feb 24, 2022 684
54gene Awards $64,000 Scholarship for Genomics Research. Feb 24, 2022 317
LATEST COMPANY NEWS. Feb 23, 2022 31417
LATEST COMPANY NEWS. Feb 22, 2022 16415
54gene's ACTG Awards $64,000 Scholarship to Further Genomics Research. Feb 22, 2022 794
Spikevax becomes second approved COVID vaccine. Feb 21, 2022 791
CanSinoBIO awarded China's approval for Convidecia heterologous COVID-19 booster. Feb 21, 2022 293
CanSinoBIO awarded China's approval for Convidecia heterologous COVID-19 booster. Feb 21, 2022 294
CanSinoBIO awarded China's approval for Convidecia heterologous COVID-19 booster. Feb 21, 2022 290
Signing of Grant Agreement for 'Observational Study on COVID-19 Vaccine Immunogenicity and Reactogenicity in Bhutan'. Feb 20, 2022 166
EU drug regulators to discuss Merck COVID-19 antiviral pill next week. Feb 19, 2022 173
US FDA considers approving a second Covid-19 booster shot. Reuters News Service Feb 19, 2022 206
Acadia Pharmaceuticals Resumits Supplemental New Drug Application to US FDA for Nuplazid to Treat Alzheimer's Disease Psychosis. Feb 18, 2022 360
Athersys reports grant of stock option to new CEO Daniel Camardo. Feb 18, 2022 257
Athersys reports grant of stock option to new CEO Daniel Camardo. Feb 18, 2022 253
Canada's health authority approves Novavax's COVID-19 vaccine for adults. Feb 18, 2022 215
Novavax Inc's nuvaxovid first protein-based COVID-19 vaccine authorized for use in Canada. Feb 18, 2022 237
Canada's health authority approves Novavax's COVID-19 vaccine for adults. Feb 18, 2022 211
Novavax Inc's nuvaxovid first protein-based COVID-19 vaccine authorized for use in Canada. Feb 18, 2022 233
Canada's health authority approves Novavax's COVID-19 vaccine for adults. Feb 18, 2022 214
Novavax Inc's nuvaxovid first protein-based COVID-19 vaccine authorized for use in Canada. Feb 18, 2022 236
Hong Kong sees rush to get children vaccinated against COVID-19 as cases surge. Feb 18, 2022 158
Hong Kong sees rush to get children vaccinated against COVID-19 as cases surge. Feb 18, 2022 154
Hong Kong sees rush to get children vaccinated against COVID-19 as cases surge. Feb 18, 2022 157
Moderna says Omicron COVID-19 booster may be available by August 2022. Feb 17, 2022 169
Moderna says Omicron COVID-19 booster may be available by August 2022. Feb 17, 2022 172
Moderna says Omicron COVID-19 booster may be available by August 2022. Feb 17, 2022 173
Regencell Bioscience's RGC-COV19 eliminates mild to moderate COVID-19 symptoms under six day EARTH trail. Feb 17, 2022 275
Moderna's patent application in South Africa raises concerns over Africa's COVID-19 vaccine hub. Feb 17, 2022 206
Regencell Bioscience's RGC-COV19 eliminates mild to moderate COVID-19 symptoms under six day EARTH trail. Feb 17, 2022 276
Moderna's patent application in South Africa raises concerns over Africa's COVID-19 vaccine hub. Feb 17, 2022 207
Moderna's patent application in South Africa raises concerns over Africa's COVID-19 vaccine hub. Feb 17, 2022 203
PharmaBlock names new senior vice president of Quality and Regulatory Affairs. Feb 17, 2022 162
PharmaBlock names new senior vice president of Quality and Regulatory Affairs. Feb 17, 2022 163
Tesis Biosciences Acquires US Research Institution Genome Explorations. Feb 17, 2022 279
Tesis Biosciences Acquires US Research Institution Genome Explorations. Feb 17, 2022 256
ARISTA Biotech Plans Hong Kong Cleanroom Production Plant for COVID-19 Rapid Test Kits; Donates 15,00. Feb 17, 2022 417
BioNTech set to ship mRNA COVID-19 vaccine factory kits to Africa. Feb 16, 2022 181
Twist Bioscience raises USD269.4m from upsized public offering of common stock. Feb 16, 2022 190

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |